{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:54:38Z","timestamp":1791593678472,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.bbrc.2018.05.119","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T20:04:18Z","timestamp":1527192258000},"page":"55-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Naringenin exhibits the protective effect on cardiac hypertrophy via EETs-PPARs activation in streptozocin-induced diabetic mice"],"prefix":"10.1016","volume":"502","author":[{"given":"Jie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.05.119_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.21037\/cdt.2018.01.03","article-title":"Echocardiographic feature of diabetic cardiomyopathy: where are we now?","volume":"8","author":"Neqishi","year":"2018","journal-title":"Cardionasc Diagn. Ther."},{"key":"10.1016\/j.bbrc.2018.05.119_bib2","first-page":"67","article-title":"Research progress on flavonoids in pomelo peel","volume":"439","author":"Wang","year":"2017","journal-title":"Agro-processing"},{"key":"10.1016\/j.bbrc.2018.05.119_bib3","first-page":"708","article-title":"Naringenin reduce Ang II induced hypertrophy in primary rat cardiomyocytes","volume":"38","author":"Wei","year":"2017","journal-title":"J.\u00a0Wuhan Univ."},{"key":"10.1016\/j.bbrc.2018.05.119_bib4","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.3892\/etm.2015.2816","article-title":"Naringenin attenuates pressure overload-induced cardiac hypertrophy","volume":"10","author":"Zhang","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bbrc.2018.05.119_bib5","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2891-13-17","article-title":"Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications\u2013a review","author":"Grygiel-G\u00f3rniak","year":"2014","journal-title":"Nutr. J."},{"key":"10.1016\/j.bbrc.2018.05.119_bib6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.tem.2012.05.001","article-title":"PPARs at the crossroads of lipid signaling and inflammation","volume":"23","author":"Wahli","year":"2012","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.bbrc.2018.05.119_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jff.2017.07.015","article-title":"Polydatin exhibits the hepatoprotective effects through PPAR-\u03b1\/-\u03b2 signaling pathway in Streptozocin-induced diabetic mice","volume":"36","author":"Xue","year":"2017","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.bbrc.2018.05.119_bib8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11892-013-0375-y","article-title":"Diabetes mellitus and inflammation","volume":"13","author":"Lontchi-Yimagou","year":"2013","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.bbrc.2018.05.119_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/B978-0-12-404717-4.00005-6","article-title":"Eicosanoids in metabolic syndrome","volume":"66","author":"Hardwick","year":"2013","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.bbrc.2018.05.119_bib10","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.pharmthera.2009.12.002","article-title":"Effect of cytochrome P450 polymorphism onarachidonic acid metabolism and their impact on cardiovascular diseases","volume":"125","author":"Zordoky","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2018.05.119_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/bcp.12603","article-title":"The role of epoxyeicosatrienoic acids in the cardiovascular system","volume":"80","author":"Yang","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbrc.2018.05.119_bib12","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.addr.2011.03.006","article-title":"The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diaeases","volume":"63","author":"Xu","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbrc.2018.05.119_bib13","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/acel.12507","article-title":"CYP2J2 and its metabolites (epoxyeicosatrienoic acids) sttenuates cardiac hypertrophy by activating AMPK\u03b12 and enhancing nuclear translocation of Akt1","volume":"15","author":"Wang","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbrc.2018.05.119_bib14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.yjmcc.2014.05.016","article-title":"Epoxyeicosatrienoic acids and cardioprotection: the road to translation","volume":"74","author":"Oni-Orisan","year":"2014","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbrc.2018.05.119_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/01635581.2015.976320","article-title":"Chemopreventive and therapeutic potential of \u201cnaringenina flavanone\u201d present in citrus fruits","volume":"67","author":"MIR","year":"2015","journal-title":"Nutr. Canc."},{"key":"10.1016\/j.bbrc.2018.05.119_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00394-010-0117-8","article-title":"Dietary naringenin increases hepatic peroxisome proliferators-activated receptor \u03b1 protein expression and decreases plasma triglyceride and adiposity in rats","volume":"50","author":"Cho","year":"2011","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.bbrc.2018.05.119_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012399","article-title":"Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARalpha, PPARgamma and LXRalpha","volume":"5","author":"Goldwasser","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2018.05.119_bib18","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.3892\/mmr.2015.4232","article-title":"Naringin ameliorates cognitive deficits via oxidative stress, proinflammatory factors and the PPAR\u03b3 signaling pathway in a type 2 diabetic rat model","volume":"12","author":"Qi","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2018.05.119_bib19","first-page":"30050","article-title":"Comorbidities and cardiometabolic disease: relationship with longitudinal changes in diastolic function","volume":"S2213\u20131779","author":"Nayor","year":"2018","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.bbrc.2018.05.119_bib20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.hfc.2012.06.007","article-title":"Diabetic cardiomyopathy: bench to bedside","volume":"8","author":"Schilling","year":"2012","journal-title":"Heart Fail. Clin."},{"key":"10.1016\/j.bbrc.2018.05.119_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cbi.2017.12.007","article-title":"Isolated mangiferin and naringenin exert antidiabetic effect via PPAR(\u03b3)\/GLUT4 dual agonistic action with strong metabolic regulation","volume":"280","author":"Singh","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbrc.2018.05.119_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrendo.2016.135","article-title":"PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD","volume":"13","author":"Gross","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbrc.2018.05.119_bib23","doi-asserted-by":"crossref","first-page":"744","DOI":"10.4330\/wjc.v6.i8.744","article-title":"Peroxisome proliferator-activated receptors for hypertension","volume":"6","author":"Usuda","year":"2014","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.bbrc.2018.05.119_bib24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0092-8674(00)81118-6","article-title":"A\u00a0CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors","volume":"85","author":"Kamei","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2018.05.119_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.mce.2013.03.006","article-title":"Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-\u03b1 partly via preventing p65-NF\u03baB binding to NFATc4","volume":"370","author":"Zou","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbrc.2018.05.119_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbalip.2010.11.002","article-title":"PPAR\u03b2\/\u03b4 activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells","volume":"1811","author":"Alvarez-Guardia","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2018.05.119_bib27","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1159\/000369747","article-title":"Activation of peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) through NF-\u03baB\/Brg1 and TGF-\u03b21 pathways attenuates cardiac remodeling in pressure-overloaded rat hearts","volume":"35","author":"Qi","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbrc.2018.05.119_bib28","first-page":"4256","article-title":"Effects of Polydatin on myocardial hypertrophy in mice with diabetes mellitus and its mechanism","volume":"40","author":"Huang","year":"2015","journal-title":"China J. Chin. Mater. Med."},{"key":"10.1016\/j.bbrc.2018.05.119_bib29","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jdiacomp.2015.04.012","article-title":"PPAR\u03b3-PI3K\/AKT-NO signal pathway is involved in cardiomyocyte hypertrophy induced by high glucose and insulin","volume":"29","author":"Peng","year":"2015","journal-title":"J.\u00a0Diabetes Complicat."},{"key":"10.1016\/j.bbrc.2018.05.119_bib30","first-page":"285489","article-title":"Effect of berberine on PPAR\u03b1 activation in high glucose- and insulin-induced cardiomyocyte hypertrophy","author":"Wang","year":"2013","journal-title":"Evid-Based Compl. Alt."},{"key":"10.1016\/j.bbrc.2018.05.119_bib31","first-page":"6","article-title":"Effects of naringin and naringenin on the levels of peroxisome proliferator-activated receptor-\u03b4 in monocytes of hyperlipidemia model rats","volume":"18","author":"Yang","year":"2013","journal-title":"Chin. J. Clin. Pharmacol. Therapeut."},{"key":"10.1016\/j.bbrc.2018.05.119_bib32","first-page":"2891","article-title":"Affinity and intrinsic activity of naringenin with hPPARs","volume":"23","author":"Luo","year":"2012","journal-title":"Chin. Pharm."},{"key":"10.1016\/j.bbrc.2018.05.119_bib33","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3945\/an.116.012245","article-title":"The role of cytochrome P450 epoxygenases, soluble epoxide hydrolase, and epoxyeicosatrienoic acids in metabolic diseases","volume":"7","author":"Xu","year":"2016","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.bbrc.2018.05.119_bib34","first-page":"605101","article-title":"Anti-inflammatory effects of epoxyeicosatrienoic acids","author":"Thomson","year":"2012","journal-title":"Int. J. Vasc. Med."},{"key":"10.1016\/j.bbrc.2018.05.119_bib35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-319-16009-2_6","article-title":"Cytochrome p450 enzymes in the bioactivation of polyunsaturated Fatty acids and their role in cardiovascular disease","volume":"851","author":"Westphal","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbrc.2018.05.119_bib36","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00118.2014","article-title":"CYP2J2 attenuates metabolic dysfunction in diabetic mice by reducing hepatic inflammation via the PPAR\u03b3","volume":"308","author":"Li","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18311823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18311823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:32:58Z","timestamp":1762093978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18311823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0006291X18311823"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.05.119","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naringenin exhibits the protective effect on cardiac hypertrophy via EETs-PPARs activation in streptozocin-induced diabetic mice","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.05.119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}